ImmunoPrecise to Present at the Virtual Gravitas Healthcare Investor Day
ImmunoPrecise to Present at the Virtual Gravitas Healthcare Investor Day |
[28-September-2020] |
VICTORIA, BC, Sept. 28, 2020 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV: IPA) (OTCQB: IPATF) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that Dr. Jennifer Bath, ImmunoPrecise's Chief Executive Officer, will present an overview of the company at the Gravitas Healthcare Investor Day on Thursday, October 1st at 11:00 AM EST. This year's Gravitas Healthcare Investor Day will feature several leaders in healthcare and will be attended virtually by institutional and retail investors from North America and abroad. For additional details about the conference and Gravitas Securities Inc., please visit: www.gravitassecurities.com Conference Details:
About ImmunoPrecise Antibodies Ltd. SOURCE ImmunoPrecise Antibodies Ltd. | ||||||||||
Company Codes: OTC-QB:IPATF, TorontoVE:IPA, Frankfurt:TQB2 |
© 2020 PR Newswire. All Rights Reserved.